Limitations
of MEA or patch clamp approaches.
Our results reproduced classical excitotoxic responses to injury, including calcium
dyshomeostasis and synchronized burst firing. These findings are consistent with previous
work reporting increased membrane permeability
[44, 45], dysregulation of voltage-gated Na /i4
channels[46, 47], and glutamate-induced excitotoxicity [48]. The increased cleavage of calpain-1
observed via western blot further confirmed calcium dysregulation. Calpain, a calcium-
activated protease, undergoes autolysis in the presence of elevated Ca² /i4 levels [49], thereby
facilitating excitotoxic damage by proteolyzing voltage-gated Na /i4 channels [50, 51] and
promoting tauopathy.
Our functional connectivity analysis revealed that early post-injury synchrony was followed
by significant reductions in connectivity strength, depolarization, and reorganization of
neuronal clusters. These late-phase changes suggest long-term depression (LTD)-like
plasticity, potentially mediated by decreased calcium influx, a known trigger for shifting
synaptic strength from potentiation (LTP) to LTD
[52, 53] . The reduced network amplitude
observed aligns with these LTD-associated mechanisms, characterized by lower wPL and
increased community isolation. These data present a comprehensive view of the temporal
evolution of neuronal injury responses across both cellular and network dimensions.
To investigate molecular correlations of these functional transitions, we profiled secreted
proteins across injury time points. While neuronal production of inflammatory cytokines is
known
[54-71] , our study provides one of the first high-resolution temporal maps of cytokine
secretion from pure neuronal populations. We identified 24 secreted proteins, many of which
play roles in regulating neuronal function and inflammatory signaling
[65, 66, 72-78] . Secretome
dynamics revealed temporally defined waves of release: early (e.g., PAI-1, BDNF, IL-8, IP-
10), mid (e.g., IL-1 family, PDGF-AA), and late-phase (e.g., IL-13, MPO) factors. Notably,
many of these proteins are also upregulated within 3 days post-TBI in both human and animal
studies
[79-83].
We propose that early-stage excitotoxicity and hyperactivity likely drive the release of
activity-regulated factors, as suggested by high canonical correlations between IP-10, IL-10,
IFN
α 2, NCAM, and injury-induced activity changes. IP-10 and NCAM, in particular, are
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprintthis version posted August 9, 2025. ; https://doi.org/10.1101/2025.08.06.667201doi: bioRxiv preprint
16
upregulated via calcium-dependent gene expression mechanisms[84-86], and the involvement of
CDK5 and calpain in tau hyperphosphorylation has been well established. While direct
activity-dependence of IL-10 and IFN α 2 remains uncertain, their tight association with early
injury responses suggests indirect regulation through other neuronal signaling cascades.
Network analysis further revealed IP-10, NCAM, IL-10, M-CSF as central hubs in autocrine
regulatory circuits, indicating a mechanistic link between neuronal activity and inflammatory
secretome progression.
Interestingly, we found that many injury-induced secreted proteins are components of the
senescence-associated secretory phenotype (SASP), which exerts autocrine and paracrine
effects in aged tissues
[87-91]. These include early-phase proteins (e.g., IL-8, GM-CSF), mid-
phase (e.g., FGF2, IL-4), and late-phase (e.g., IL-13, VEGF-A). In parallel, we identified non-
SASP factors such as MPO and Cathepsin D, which have been directly linked to tau
pathology[15, 54, 92-96] . Together, these findings suggest that neuronal injury alone can
recapitulate aging-like secretory patterns and drive neurodegenerative changes, independent
of glial involvement. These molecular profiles coincide temporally with the observed shift
from early hyperexcitability to late-phase LTD, supporting existing links between aging,
synaptic weakening, and tau aggregation
[97-100].
The extracellular release of A β was decreased following injury, consistent with human CSF
profiles post-TBI[101, 102] . This reduction may reflect enhanced intracellular accumulation of
Aβ due to upregulated APP processing via injury-induced neuronal activity[103-106]. In contrast,
extracellular tau (total and pT181) increased significantly, confirming previous TBI findings[9,
10], and implicating neuronal activity in tau release regulation [107, 108] . The increase in
extracellular Tau along with simultaneous decline in intracellular total Tau and rise in
intracellular pT181 suggests accumulation of hyperphosphorylated tau species that potentially
contribute to the formation of tau aggregates and neurofibrillary tangles.
Importantly, we observed significant upregulation of calpain-1, cathepsin D, and active
caspase-3,enzymes known to cleave tau at specific sites and generate neurotoxic
fragments
[109-111]. Tau truncation products such as Tau151-391 have been shown to exhibit
high aggregation propensity and pathological phosphorylation [112]. Calpain-1 and caspase-3
are primarily responsible for the formation of tau fragments [109, 113] . Calpain-1 produces a
cleaved form of ~ 78 kDa [113] and activated forms at ~ 55 and 32 kDa [109, 114-116] by autolysis.
In our study, we observed that these activated forms of calpain-1 were elevated post-injury
followed by increased active caspase-3 early in injury. Indeed, studies have shown that
calpain-1 knockout mice lack the ability to increase caspase-3 and its active form after injury
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprintthis version posted August 9, 2025. ; https://doi.org/10.1101/2025.08.06.667201doi: bioRxiv preprint
17
[35], suggesting that calpain-1 directly produces active caspase-3 in our model. Additionally,
the total Tau antibody Tau46, detects AA404-441 on the C-terminal of Tau protein, which can
be cleaved by the three proteinases. The significant decrease of intracellular Tau46+ staining
post-injury is consistent with enhanced tau truncation.
This study demonstrates that a 3D Neuron-on-Chip model using hPSC-derived excitatory
hPFC neurons can recapitulate key features of neuronal injury over an extended post-injury
timeline. We report acute excitotoxic responses, progressive functional connectivity loss, and
the emergence of a neurodegenerative and SASP-like secretome, all in the absence of glial
contribution. These findings highlight an intrinsic neuronal mechanism for tauopathy
development following neuronal injury and offer a unique platform to dissect cell-
autonomous injury responses relevant to TBI and Alzheimer’s disease progression.
4. Methods
Device Fabrication: Negative device molds were 3D printed using Clear-V4 resin
(Formlabs™, Cat# RS-F2-GPCL-04) on a Formlabs 3 printer. PDMS (Sylgard™ 184, Dow
Corning) was mixed in a 10:1 base-to-curing agent ratio, and 7 mL of the mixture was poured
into 60 mm Petri dishes containing seven molds that were held in place with mineral oil.
Device molds and PDMS mixture were degassed under vacuum (30 min) and cured at 80°C
for 3 hours to result in polymerized PDMS devices that were ~22 mm in height. Polymerized
PDMS using the above ratio of base polymer and curing agent has been previously
characterized to have an elastic modulus of ~1.3-3 MPa
[117]. The devices were removed from
60 mm petri dish by a biopsy punch with a radius of 7 mm and then immobilized to 35 mm
glass bottom dishes (Cellvis) using PDMS base mixture. The devices were returned to the
oven to bake for another 3 hours at 80°C, then sterilized in 70% ethanol and air-dried before
seeding cells.
Cell Culture of hPSC-Derived Prefrontal Cortex Neurons: Human pluripotent stem cells
(hPSCs) derived prefrontal cortex neurons (hPFCs) were generated following methods
described previously
[40]. hPSCs were dissociated into single cells and plated on Matrigel-
coated plates in Essential 8 medium with 10 μ M ROCK inhibitor. From day 0–2, cultures
were treated with Essential 6 medium containing 2 μ M XAV939, 100 nM LDN193189, and
10 μ M SB431542. XAV939 was withdrawn from day 2 onward. At day 6–8, cells were
replated as high-density droplets on poly-ornithine/laminin/fibronectin-coated dishes and
cultured in N2 medium with B27 (1:1000, no vitamin A), FGF8 (50 ng/mL), and SHH (25
ng/mL) for 4 days, until neuroepithelial rosettes were visible. Droplets were then passaged 1:2
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprintthis version posted August 9, 2025. ; https://doi.org/10.1101/2025.08.06.667201doi: bioRxiv preprint
18
with trypsin onto poly-ornithine/laminin/fibronectin coated plates and cultured in the same
media. On day 16, cells were passaged using Accutase and plated at 1×10 /i4 cells/cm² in PFC
medium (Neurobasal™, B27 1:50, N2 1:100, GlutaMAX 1:100). FGF8 (50 ng/mL) was
supplemented during the first two weeks. Cells were passaged again on day 22, replated at
100,000 cells/cm2 and used for experiments on day 35.
Hydrogel encapsulation of hPFC neurons: iPSC-derived hPFC neurons were suspended in
GeltrexTM at a concentration of 20,000 cells/
μ L. 10 μ L of mixture was quickly dispensed
into each cell chamber (B1, B2) of the device. The device was then incubated at 37°C/5%
CO2 for 30 minutes to facilitate polymerization before 200 μ L of PFC media was added into
the device. Media change was performed daily thereafter.
Weight-Drop Injury Induction: hPFC neurons in the device were allowed to mature for 2
weeks before being subjected to weight-drop injury. A weight drop apparatus was designed
and built based on Feeney’s weight drop injury model [118, 119] . Both chambers within each
Neuron-on-Chip device received a focal injury with a 6-gram weight dropped from a height of
15 cm (impact velocity ≈ 1.72 m s-1, acceleration ≈ 1 g, force ≈ 9 mJ, force/area on PDMS
shell ≈ 11.4 mJ mm-2).
Calcium imaging: Calcium imaging was performed immediately after injury (0.5h), 24 h and
72 h post-injury. Fluo-4 AM (Thermo Fisher) was dissolved in 20% Pluronic F-127 (in
DMSO) and diluted (10 μ L/mL) in PFC media to reach a 10 μ M final concentration. A
loading solution was made by adding 8 μ L of stock solution to 1 mL of PFC media. Media in
the device was replaced with loading solution and the device was incubated for 60 minutes.
The device was transferred back to PFC media for recording. Calcium recordings were
acquired using Leica DM-IRBE inverted microscope with a FITC filter (Ex/Em: 488/525
mm). Images from 3 regions of interest (ROIs; B1, B2, and region between the two) were
obtained separately for 5 minutes at 20 fps with 50 ms exposure. The device and cells were
maintained under physiological conditions (37°C with 5% CO2 medical grade air mixture
(Airgas, PA)) in a microscope stage top incubator (Tokai hit live cell culture stage adapter)
for the entire recording session.
Neuronal Activity and Network Analysis: Calcium traces were extracted using custom
MATLAB® scripts. Deconvolution and spike estimation was performed using MATLAB
script developed by Pnevmatikakis
[19]. Waveform features (rise/fall time, pulse width, and
amplitude) were calculated using methods published previously [20].
Network analysis was assessed via pair-wise phase-locking synchronization matrix using
previously published methods
[31]. Briefly, each neuron j has a discrete sequence of spike
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprintthis version posted August 9, 2025. ; https://doi.org/10.1101/2025.08.06.667201doi: bioRxiv preprint
19
times, /g1675/g3037 /g4666/g1666/g4667 , and a time-varying instantaneous phase was assigned to each neuron j within the
nth inter-spike interval (1).
/g5030 /g3037 /g4666 /g1675, /g1666 /g4667 /g34042 /g5054 /g1666/g33∑72 /g5054 /g1675/g33∑6/g1675 /g3037 /g4666/g1666/g4667
/g1675/g3037 /g4666 /g1666/g33∑71 /g4667 /g33∑6/g1675 /g3037 /g4666/g1666/g4667 /g46661/g4667
Pair-wise phase-locking synchronization matrix C of neurons with total number of M was
generated by calculating circular variance of the phase difference between pair-wise neurons j
and k (2).
/g1645 /g3037/g3038 /g3404 /g3657 /g1657 /g3036/g4666/g3101 /g3285/g4666 /g3047 /g4667 /g2879/g3101 /g3285/g3286/g4666 /g3047 /g4667 /g4667 /g3657 /g46662/g4667
To obtain a normalized value of global synchronization index (GSI), which ranges from 0
(non-coordinated activity) to 1 (perfectly synchronized activity), and independent of the
number of neurons, we followed previously published eigen-value based decomposition
approaches
[120, 121]. The eigenvalue decomposition of C can be given by (3)
/g165∑/g1674 /g3036 /g3404/g501∑ /g3036 /g1674 /g3036 /g46663/g4667
Where /g501∑ /g3036 is the eigenvalue and /g501∑ /g2869 /g340∑/g501∑ /g2870 /g340∑/g1710/g340∑/g501∑ /g3014 , and /g1674 /g3036 is the eigenvector corresponding
to /g501∑ /g3036 . Surrogate matrices of matrix C were generated using the amplitude-adjusted Fourier
transform (AAFT) and repeated 10 times. The mean of eigen-value calculated across 10
surrogates is denoted as /g501∑ /g11∑1/g3036 . The normalized GSI can be computed by (4)
/g1633/g1645/g1635 /g3404 /g4666
/g501∑ /g3014 /g33∑6/g501∑ /g11∑1/g3014
/g163∑/g33∑6/g501∑ /g11∑1/g3014
,/g1661 /g1656 /g501∑ /g3014 /g3406/g501∑ /g11∑1/g3036
0, /g1667/g1675/g1660/g1657/g1670/g1675/g1661/g1671/g1657
/g1 /g46664/g4667
The equation to compute the number of clusters is expressed as (5)
/g1640/g1673/g1665/g165∑/g1664/g1673/g1671/g1675/g1657/g1670 /g3404 /g3533 /g1671/g165∑/g1666/g4666
/g3038
/g501∑ /g3038 /g3406 /g3435 /g501∑ /g11∑1/g3038 /g33∑7/g1637/g3400/g1645 /g1630 /g3038 /g343∑ /g46665/g4667
Where sng is 1 if /g501∑ /g3038 /g3406/g4666 /g501∑ /g11∑1/g3036 /g33∑7/g1637/g3400/g1645 /g1630 /g3038 /g4667 is true, K is a constant (here K = 2, giving 95%
confidence levels), /g501∑ /g11∑1/g3038 is the average and /g1645/g1630 /g3038 is the standard deviation of surrogate
eigenvalues.
Weighted Modularity (/g1643 /g3050 ) describes the degree to which the network may be subdivided into
such clearly delineated and nonoverlapping groups, which was measured following previously
published method [32, 33] (6).
/g1643 /g3050 /g3404 1
/g1664 /g3050 /g3533/g4660 /g1675 /g3036/g3037 /g33∑6
/g1663 /g3036
/g3050 /g1663 /g3037
/g3050
/g1664 /g3050 /g4661/g5015 /g3040 /g3284,/g3040 /g3285
/g3036,/g3037/g3106/g3015
/g46666/g4667
Where i, j are the nodes in the network, and N is the set of all nodes in the network. /g1675 /g3036/g3037 is the
weight of the link (i,j); Sum of all weights in the network, /g1664 /g3050 /g3404 ∑ /g1675 /g3036/g3037/g3036,/g3037/g3106/g3015 ; Weight degree of i,
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprintthis version posted August 9, 2025. ; https://doi.org/10.1101/2025.08.06.667201doi: bioRxiv preprint
20
/g1663 /g3036
/g3050 /g3404 ∑ /g1675 /g3036/g3037/g3037/g3106/g3015 ; /g1665 /g3036 is the module containing node i, which is determined by Louvain
clustering, and /g5015 /g3040 /g3284,/g3040 /g3285/g34041 if /g1665 /g3036 /g3404/g1665 /g3037 , otherwise /g5015 /g3040 /g3284,/g3040 /g3285/g34040 .
Weighted Global Efficiency ( /g1631 /g3050 ) is the average inverse shortest path length. It describes the
integration of the network and how efficiently the network exchange information. /g1631 /g3050 was
calculated following previously published method [33, 122] (7).
/g1631 /g3050 /g3404 1
/g1666 /g3533
∑ /g4666/g1656 /g3036/g3037
/g3050 /g4667 /g2879/g2869
/g3037/g3106/g3015,/g3037/g2999/g3036
/g1666/g33∑61/g3036/g3106/g3015
/g46667/g4667
Where i, j are the nodes in the network, and n is the number of nodes in the network; Shortest
weighted path length between i and j, /g1656 /g3036/g3037
/g3050 /g3404 ∑ /g1656/g4666/g1675 /g3048/g3049 /g4667/g3028 /g3296/g3297/g3354/g3282/g3284/g1374/g3285
/g3298 , where f is a map from weight
to length and /g165∑ /g3036/g1374/g3037
/g3050 is the shortest weighted path between i and j.
Immunocytochemical analysis: The devices were fixed with 4% (w/v) paraformaldehyde and
0.4 M sucrose in PBS for 20 min at RT. Next, the devices were washed with PBST (0.5%
(v/v) TritonX-100 in PBS) and permeabilized for 1 h with blocking solution (5% (w/v) BSA
in PBST). Primary antibody incubation was performed overnight at 4°C in blocking solution.
The devices were then washed with PBST twice and incubated with blocking solution for 1 h
at RT. Secondary antibody incubations were performed for 3 h at RT in blocking solution,
followed by 30 min incubation with Hoechst. Unbound antibodies and Hoechst were washed
away by washing 2 times with PBS. 10X images were acquired on a Zeiss LSM 900 confocal
microscope (Zeiss, Germany) and analyzed using custom MATLAB scripts.
Primary antibodies include: pS396 Tau (Abcam #ab109390), pT231 Tau (Abcam #ab151559),
Tau 46 (Cell Signaling #4019S), AT8 (ThermoFisher #MN1020), Beta III-Tubulin (EMD
Millipore #ab9354), Synaptophysin-1 (Abcam #ab14692). Secondary antibodies include: 488
Goat anti-Chicken IgY (ThermoFisher #A11039), 594 Goat anti-Rabbit IgG(H+L)
(ThermoFisher #A21428), 647 Goat anti-Mouse IgG1 (ThermoFisher #20240), 647 Goat anti-
Rabbit IgG(H+L) (ThermoFisher #21244).
Western Blotting: Cells were extracted from hydrogels, washed once with ice-cold DPBS
without Ca/Mg, and then lysed in RIPA buffer (ThermoFisher, Waltham) supplemented with
1X Halt Protease & Phosphatase Inhibitor cocktail (Thermo Scientific, Waltham), on ice for
30 min, with intermittent vortexing. Cell lysates were spun down at 14,000 RPM for 20
minutes, at 4
/i4 C. Supernatants were collected and protein amounts were estimated using
Pierce BCA Protein Assay kit (ThermoFisher, Waltham). Sodium dodecyl-sulfate
polyacrylamide gel electrophoresis (SDS-PAGE) was run to resolve proteins (10
μ g per lane)
and transferred onto nitrocellulose membranes. The membranes were blocked for 1 h using
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprintthis version posted August 9, 2025. ; https://doi.org/10.1101/2025.08.06.667201doi: bioRxiv preprint
21
5% non-fat dry milk in TBST and incubated with primary antibodies – Calpain-1 (#MA3-940,
Invitrogen), Caspase-3 (#9662, Cell Signaling), pT181 (#MN1050, Thermo), Tau46 (#4019S,
CST), pS396 (#ab109390, Abcam), AT8 (#MN1020, Thermo), pT231 (#ab151559, Abcam)
and
β -actin (#4970S, CST) in 5% BSA in TBST, at 4°C overnight. This was followed by
secondary antibody incubation for 1 h at room temperature. Immunoblots were developed
using Clarity Western ECL substrate (170-5060, Bio-Rad) and digital images were acquired
using the ChemiDoc MP imaging system (Bio-Rad). Quantification of protein bands was
performed using ImageJ software (NIH) and band intensities were normalized to respective
β -
actin and Tau46 loading controls.
Secretome Analysis: Conditioned media was collected before each calcium imaging session at
24 h, 72 h, 5d and 8d time points. Pooled replicates were analyzed using 48-plex, human
supplemental biomarker 10-plex, and human amyloid beta and tau 4-plex discovery assays
(Eve Technologies). Low-abundance proteins were excluded. Proteins with log
/i4 fold change
>0.3 (injury vs. control) at any time point were retained, identifying 24 cytokines and 4 tau-
related markers. These log2 fold change values of each marker at each time point were
subjected to hierarchical clustering using the Ward algorithm
[123] for their release profile.
Next, a cross-correlation matrix of absolute fluorescence values from the 28 markers was used
to compute an adjacency matrix after removing non-significant correlations (p-value < 0.5).
Functional clusters were visualized using a spectral clustering algorithm, and the functional
association of the markers was plotted using a force directed graph. To correlate secretome
with neuronal function, sparse canonical correlation analysis (sCCA) was applied to averaged
calcium imaging metrics from corresponding biological replicates.
References
1. Hayes, J. P., Bigler, E. D., and Verfaellie, M., "Traumatic Brain Injury as a Disorder
of Brain Connectivity". J Int Neuropsychol Soc (2016). 22(2): p. 120-37.
2. Dennis, E. L., Vervoordt, S., Adamson, M. M., et al., "Accelerated Aging after
Traumatic Brain Injury: An ENIGMA Multi-Cohort Mega-Analysis". Ann Neurol
(2024). 96(2): p. 365-377.
3. Amgalan, A., Maher, A. S., Ghosh, S., et al., "Brain age estimation reveals older
adults’ accelerated senescence after traumatic brain injury". GeroScience (2022).
44(5): p. 2509-2525.
4. Cole, J. H., Leech, R., Sharp, D. J., and Initiative, f. t. A. s. D. N., "Prediction of brain
age suggests accelerated atrophy after traumatic brain injury". Annals of Neurology
(2015). 77(4): p. 571-581.
5. Assiociation, A. s., Traumatic Brain Injury (TBI).
6. Mudher, A., Colin, M., Dujardin, S., et al., "What is the evidence that tau pathology
spreads through prion-like propagation?". Acta Neuropathologica Communications
(2017). 5(1): p. 99.
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprintthis version posted August 9, 2025. ; https://doi.org/10.1101/2025.08.06.667201doi: bioRxiv preprint
23
7. Edwards, G., 3rd, Zhao, J., Dash, P. K., Soto, C., and Moreno-Gonzalez, I.,
"Traumatic Brain Injury Induces Tau Aggregation and Spreading". J Neurotrauma
(2020). 37(1): p. 80-92.
8. Saha, P. and Sen, N., "Tauopathy: A common mechanism for neurodegeneration and
brain aging". Mech Ageing Dev (2019). 178: p. 72-79.
9. Johnson, V. E., Stewart, W., and Smith, D. H., "Widespread τ and amyloid-β
pathology many years after a single traumatic brain injury in humans". Brain Pathol
(2012). 22(2): p. 142-9.
10. Edwards, G., Zhao, J., Dash, P. K., Soto, C., and Moreno-Gonzalez, I., "Traumatic
Brain Injury Induces Tau Aggregation and Spreading". Journal of Neurotrauma
(2020). 37(1): p. 80-92.
11. Ost, M., Nylen, K., Csajbok, L., et al., "Initial CSF total tau correlates with 1-year
outcome in patients with traumatic brain injury". Neurology (2006). 67(9): p. 1600-
1604.
12. Magnoni, S., Esparza, T. J., Conte, V., et al., "Tau elevations in the brain extracellular
space correlate with reduced amyloid-β levels and predict adverse clinical outcomes
after severe traumatic brain injury". Brain (2012). 135(4): p. 1268-1280.
13. Shahim, P., Tegner, Y., Gustafsson, B., et al., "Neurochemical aftermath of repetitive
mild traumatic brain injury". JAMA neurology (2016). 73(11): p. 1308-1315.
14. Collins-Praino, L. E. and Corrigan, F., "Does neuroinflammation drive the
relationship between tau hyperphosphorylation and dementia development following
traumatic brain injury?". Brain, Behavior, and Immunity (2017). 60: p. 369-382.
15. Zhou, F., Sun, Y., Xie, X., and Zhao, Y., "Blood and CSF chemokines in Alzheimer’s
disease and mild cognitive impairment: a systematic review and meta-analysis".
Alzheimer's Research & Therapy (2023). 15(1): p. 107.
16. Finley, M., Fairman, D., Liu, D., et al., "Functional validation of adult hippocampal
organotypic cultures as an in vitro model of brain injury". Brain Research (2004).
1001(1): p. 125-132.
17. Chen, W., Sheng, J., Guo, J., et al., "Cytokine cascades induced by mechanical trauma
injury alter voltage-gated sodium channel activity in intact cortical neurons". Journal
of Neuroinflammation (2017). 14(1): p. 73.
18. Robbins, M., Christensen, C. N., Kaminski, C. F., and Zlatic, M., "Calcium imaging
analysis - how far have we come?". F1000Res (2021). 10: p. 258.
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprintthis version posted August 9, 2025. ; https://doi.org/10.1101/2025.08.06.667201doi: bioRxiv preprint
24
19. Pnevmatikakis, E., Merel, J., Pakman, A., and Paninski, L., "Bayesian spike inference
from calcium imaging data". Conference Record - Asilomar Conference on Signals,
Systems and Computers (2013).
20. Clarkson, B. D. S., Kahoud, R. J., McCarthy, C. B., and Howe, C. L., "Inflammatory
cytokine-induced changes in neural network activity measured by waveform analysis
of high-content calcium imaging in murine cortical neurons". Scientific Reports
(2017). 7(1): p. 9037.
21. Sporns, O., "Graph theory methods: applications in brain networks". Dialogues Clin
Neurosci (2018). 20(2): p. 111-121.
22. Luo, C.-L., Chen, X.-P., Li, L.-L., et al., "Poloxamer 188 Attenuates in vitro
Traumatic Brain Injury-Induced Mitochondrial and Lysosomal Membrane
Permeabilization Damage in Cultured Primary Neurons". Journal of Neurotrauma
(2012). 30(7): p. 597-607.
23. Inyang, E., Abhyankar, V., Chen, B., and Cho, M., "Modulation of in vitro Brain
Endothelium by Mechanical Trauma: Structural and Functional Restoration by
Poloxamer 188". Scientific Reports (2020). 10(1): p. 3054.
24. Bao, H., Yang, X., Zhuang, Y., et al., "The effects of poloxamer 188 on the autophagy
induced by traumatic brain injury". Neuroscience Letters (2016). 634: p. 7-12.
25. López-García, I., Ger
ő , D., Szczesny, B., et al., "Development of a stretch-induced
neurotrauma model for medium-throughput screening in vitro: identification of
rifampicin as a neuroprotectant". British Journal of Pharmacology (2018). 175(2): p.
284-300.
26. Wu, Y.-H., Rosset, S., Lee, T.-r., et al., "In Vitro Models of Traumatic Brain Injury: A
Systematic Review". Journal of Neurotrauma (2021). 38(17): p. 2336-2372.
27. Hanna, M. E. and Pfister, B. J., "Advancements in in vitro models of traumatic brain
injury". Current Opinion in Biomedical Engineering (2023). 25: p. 100430.
28. Berridge, M. J., "Calcium microdomains: Organization and function". Cell Calcium
(2006). 40(5): p. 405-412.
29. Zhu, X., Beal, M. F., Wang, X., et al., "Neuronal Calcium Signaling, Mitochondrial
Dysfunction, and Alzheimer's Disease". Journal of Alzheimer’s Disease (2010).
20(s2): p. S487-S498.
30. Schwarz, A. J., Gozzi, A., and Bifone, A., "Community structure and modularity in
networks of correlated brain activity". Magnetic Resonance Imaging (2008). 26(7): p.
914-920.
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprintthis version posted August 9, 2025. ; https://doi.org/10.1101/2025.08.06.667201doi: bioRxiv preprint
25
31. Patel, T., Ventre, S., and Meaney, D., "Dynamic Changes in Neural Circuit Topology
Following Mild Mechanical Injury In Vitro". Annals of biomedical engineering (2012).
40: p. 23-36.
32. Newman, M. E. J., "Analysis of weighted networks". Physical Review E (2004). 70(5):
p. 056131.
33. Rubinov, M. and Sporns, O., "Complex network measures of brain connectivity: Uses
and interpretations". NeuroImage (2010). 52(3): p. 1059-1069.
34. Vosler, P. S., Brennan, C. S., and Chen, J., "Calpain-mediated signaling mechanisms
in neuronal injury and neurodegeneration". Mol Neurobiol (2008). 38(1): p. 78-100.
35. Yamada, K. H., Kozlowski, D. A., Seidl, S. E., et al., "Targeted gene inactivation of
calpain-1 suppresses cortical degeneration due to traumatic brain injury and
neuronal apoptosis induced by oxidative stress". J Biol Chem (2012). 287(16): p.
13182-93.
36. Xue, S., Rogers, L. R. K., Zheng, M., et al., "Applying differential network analysis to
longitudinal gene expression in response to perturbations". Frontiers in Genetics
(2022). 13.
37. González, I., Déjean, S., Martin, P. G. P., and Baccini, A., "CCA: An R Package to
Extend Canonical Correlation Analysis". Journal of Statistical Software (2008).
23(12): p. 1 - 14.
38. Carron, S. F., Alwis, D. S., and Rajan, R., "Traumatic Brain Injury and Neuronal
Functionality Changes in Sensory Cortex". Frontiers in Systems Neuroscience (2016).
10.
39. Carron, S. F., Alwis, D. S., and Rajan, R., "Traumatic Brain Injury and Neuronal
Functionality Changes in Sensory Cortex". Front Syst Neurosci (2016). 10: p. 47.
40. Cederquist, G. Y., Tchieu, J., Callahan, S. J., et al., "A Multiplex Human Pluripotent
Stem Cell Platform Defines Molecular and Functional Subclasses of Autism-Related
Genes". Cell Stem Cell (2020). 27(1): p. 35-49.e6.
41. Valadez-Barba, V., Cota-Coronado, A., Hernández-Pérez, O. R., et al., "iPSC for
modeling neurodegenerative disorders". Regen Ther (2020). 15: p. 332-339.
42. Zhang, X., Hu, D., Shang, Y., and Qi, X., "Using induced pluripotent stem cell
neuronal models to study neurodegenerative diseases". Biochimica et Biophysica Acta
(BBA) - Molecular Basis of Disease (2020). 1866(4): p. 165431.
43. Penney, J., Ralvenius, W. T., and Tsai, L.-H., "
Modeling Alzheimer’s disease with
iPSC-derived brain cells". Molecular Psychiatry (2020). 25(1): p. 148-167.
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprintthis version posted August 9, 2025. ; https://doi.org/10.1101/2025.08.06.667201doi: bioRxiv preprint
26
44. Slemmer, J. E., Matser, E. J. T., De Zeeuw, C. I., and Weber, J. T., "Repeated mild
injury causes cumulative damage to hippocampal cells". Brain (2002). 125(12): p.
2699-2709.
45. Ravin, R., Morgan, N. Y., Blank, P. S., et al., "Response to Blast-like Shear Stresses
Associated with Mild Blast-Induced Brain Injury". Biophysical Journal (2019).
117(7): p. 1167-1178.
46. Wolf, J. A., Stys, P. K., Lusardi, T., Meaney, D., and Smith, D. H., "Traumatic Axonal
Injury Induces Calcium Influx Modulated by Tetrodotoxin-Sensitive Sodium
Channels". The Journal of Neuroscience (2001). 21(6): p. 1923-1930.
47. Brittain, M. K., Brustovetsky, T., Sheets, P. L., et al., "Delayed calcium dysregulation
in neurons requires both the NMDA receptor and the reverse Na+/Ca2+ exchanger".
Neurobiology of Disease (2012). 46(1): p. 109-117.
48. Baracaldo-Santamaría, D., Ariza-Salamanca, D. F., Corrales-Hernández, M. G., et al.,
"Revisiting Excitotoxicity in Traumatic Brain Injury: From Bench to Bedside".
Pharmaceutics (2022). 14(1).
49. Li, H., Thompson, V. F., and Goll, D. E., "Effects of autolysis on properties of μ - and
m-calpain". Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2004).
1691(2): p. 91-103.
50. von Reyn, C. R., Mott, R. E., Siman, R., Smith, D. H., and Meaney, D. F.,
"Mechanisms of calpain mediated proteolysis of voltage gated sodium channel α -
subunits following in vitro dynamic stretch injury". J Neurochem (2012). 121(5): p.
793-805.
51. Brocard, C., Plantier, V., Boulenguez, P., et al., "Cleavage of Na(+) channels by
calpain increases persistent Na(+) current and promotes spasticity after spinal cord
injury". Nat Med (2016). 22(4): p. 404-11.
52. Evans, R. C. and Blackwell, K. T., "Calcium: amplitude, duration, or location?". Biol
Bull (2015). 228(1): p. 75-83.
53. Inglebert, Y. and Debanne, D., "Calcium and Spike Timing-Dependent Plasticity".
Frontiers in Cellular Neuroscience (2021). 15.
54. Green, P. S., Mendez, A. J., Jacob, J. S., et al., "Neuronal expression of
myeloperoxidase is increased in Alzheimer's disease". Journal of Neurochemistry
(2004). 90(3): p. 724-733.
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprintthis version posted August 9, 2025. ; https://doi.org/10.1101/2025.08.06.667201doi: bioRxiv preprint
27
55. Masliah, E., Mallory, M., Alford, M., Deteresa, R., and Saitoh, T., "PDGF is
associated with neuronal and glial alterations of Alzheimer's disease". Neurobiology
of Aging (1995). 16(4): p. 549-556.
56. Watson, A. E. S., Goodkey, K., Footz, T., and Voronova, A., "Regulation of CNS
precursor function by neuronal chemokines". Neuroscience Letters (2020). 715: p.
134533.
57. Li, S., olde Heuvel, F., Rehman, R., et al., "Interleukin-13 and its receptor are
synaptic proteins involved in plasticity and neuroprotection". Nature Communications
(2023). 14(1): p. 200.
58. Huang, Y., Smith, D. E., Ibáñez-Sandoval, O., Sims, J. E., and Friedman, W. J.,
"Neuron-specific effects of interleukin-1β are mediated by a novel isoform of the IL-1
receptor accessory protein". J Neurosci (2011). 31(49): p. 18048-59.
59. Zhao, X., Wang, H., Sun, G., et al., "Neuronal Interleukin-4 as a Modulator of
Microglial Pathways and Ischemic Brain Damage". The Journal of Neuroscience
(2015). 35(32): p. 11281-11291.
60. Ouyang, X., Wani, W. Y., Benavides, G. A., et al., "Cathepsin D overexpression in the
nervous system rescues lethality and Aβ 42 accumulation of cathepsin D systemic
knockout in vivo". Acta Pharmaceutica Sinica B (2023). 13(10): p. 4172-4184.
61. Rosenstein, J. M., Krum, J. M., and Ruhrberg, C., "VEGF in the nervous system".
Organogenesis (2010). 6(2): p. 107-14.
62. Noda, M., Takii, K., Parajuli, B., et al., "FGF-2 released from degenerating neurons
exerts microglial-induced neuroprotection via FGFR3-ERK signaling pathway".
Journal of Neuroinflammation (2014). 11(1): p. 76.
63. Takeuchi, A., Miyaishi, O., Kiuchi, K., and Isobe, K.-i., "Macrophage colony-
stimulating factor is expressed in neuron and microglia after focal brain injury".
Journal of Neuroscience Research (2001). 65(1): p. 38-44.
64. Vogel, D. Y., Kooij, G., Heijnen, P. D., et al., "GM-CSF promotes migration of human
monocytes across the blood brain barrier". Eur J Immunol (2015). 45(6): p. 1808-19.
65. Herrmann, K. A. and Broihier, H. T., "What neurons tell themselves: autocrine signals
play essential roles in neuronal development and function". Curr Opin Neurobiol
(2018). 51: p. 70-79.
66. Yang, J., Ding, H., Shuai, B., Zhang, Y., and Zhang, Y., "Mechanism and effects of
STING–IFN-I pathway on nociception: A narrative review". Frontiers in Molecular
Neuroscience (2023). 15.
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprintthis version posted August 9, 2025. ; https://doi.org/10.1101/2025.08.06.667201doi: bioRxiv preprint
28
67. Fryer, A. D., Stein, L. H., Nie, Z., et al., "Neuronal eotaxin and the effects of CCR3
antagonist on airway hyperreactivity and M2 receptor dysfunction". J Clin Invest
(2006). 116(1): p. 228-36.
68. Michael, B. D., Bricio-Moreno, L., Sorensen, E. W., et al., "Astrocyte- and Neuron-
Derived CXCL1 Drives Neutrophil Transmigration and Blood-Brain Barrier
Permeability in Viral Encephalitis". Cell Rep (2020). 32(11): p. 108150.
69. Yamamoto, K., Takeshita, K., Kojima, T., Takamatsu, J., and Saito, H., "Aging and
plasminogen activator inhibitor-1 (PAI-1) regulation: implication in the pathogenesis
of thrombotic disorders in the elderly". Cardiovascular Research (2005). 66(2): p.
276-285.
70. Westphal, D., Sytnyk, V., Schachner, M., and Leshchyns'ka, I., "Clustering of the
neural cell adhesion molecule (NCAM) at the neuronal cell surface induces caspase-
8- and -3-dependent changes of the spectrin meshwork required for NCAM-mediated
neurite outgrowth". J Biol Chem (2010). 285(53): p. 42046-57.
71. Robinson, K. F., Narasipura, S. D., Wallace, J., Ritz, E. M., and Al-Harthi, L.,
"Negative regulation of IL-8 in human astrocytes depends on β -catenin while positive
regulation is mediated by TCFs/LEF/ATF2 interaction". Cytokine (2020). 136: p.
155252.
72. Sil, S., Periyasamy, P., Thangaraj, A., Chivero, E. T., and Buch, S., "PDGF/PDGFR
axis in the neural systems". Mol Aspects Med (2018). 62: p. 63-74.
73. Del Rey, A., Verdenhalven, M., Lörwald, A., et al., "Brain-borne IL-1 adjusts
glucoregulation and provides fuel support to astrocytes and neurons in an
autocrine/paracrine manner". Molecular psychiatry (2016). 21(9): p. 1309-1320.
74. Ogunshola, O. O., Antic, A., Donoghue, M. J., et al., "Paracrine and Autocrine
Functions of Neuronal Vascular Endothelial Growth Factor (VEGF) in the Central
Nervous System*". Journal of Biological Chemistry (2002). 277(13): p. 11410-11415.
75. Zamburlin, P., Ruffinatti, F. A., Gilardino, A., et al., "Calcium signals and FGF-2
induced neurite growth in cultured parasympathetic neurons: spatial localization and
mechanisms of activation". Pflügers Archiv - European Journal of Physiology (2013).
465(9): p. 1355-1370.
76. Runge, E. M., Setter, D. O., Iyer, A. K., et al., "Cellular Sources and Neuroprotective
Roles of Interleukin-10 in the Facial Motor Nucleus after Axotomy". Cells (2022).
11(19): p. 3167.
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprintthis version posted August 9, 2025. ; https://doi.org/10.1101/2025.08.06.667201doi: bioRxiv preprint
29
77. Schäbitz, W.-R., Krüger, C., Pitzer, C., et al., "A Neuroprotective Function for the
Hematopoietic Protein Granulocyte-Macrophage Colony Stimulating Factor (GM-
CSF)". Journal of Cerebral Blood Flow & Metabolism (2008). 28(1): p. 29-43.
78. Petrisko, T. J., Bloemer, J., Pinky, P. D., et al., "Neuronal CXCL10/CXCR3 Axis
Mediates the Induction of Cerebral Hyperexcitability by Peripheral Viral Challenge".
Front Neurosci (2020). 14: p. 220.
79. Gustafsson, D., Klang, A., Thams, S., and Rostami, E., "The Role of BDNF in
Experimental and Clinical Traumatic Brain Injury". Int J Mol Sci (2021). 22(7).
80. Hayakawa, M., Tsuchida, T., Honma, Y., et al., "Fibrinolytic system activation
immediately following trauma was quickly and intensely suppressed in a rat model of
severe blunt trauma". Sci Rep (2021). 11(1): p. 20283.
81. Helmy, A., Carpenter, K. L., Menon, D. K., Pickard, J. D., and Hutchinson, P. J., "The
Cytokine Response to Human Traumatic Brain Injury: Temporal Profiles and
Evidence for Cerebral Parenchymal Production". Journal of Cerebral Blood Flow &
Metabolism (2011). 31(2): p. 658-670.
82. Di Battista, A. P., Rhind, S. G., Hutchison, M. G., et al., "Inflammatory cytokine and
chemokine profiles are associated with patient outcome and the hyperadrenergic state
following acute brain injury". Journal of Neuroinflammation (2016). 13(1): p. 40.
83. Tweedie, D., Karnati, H. K., Mullins, R., et al., "Time-dependent cytokine and
chemokine changes in mouse cerebral cortex following a mild traumatic brain injury".
eLife (2020). 9: p. e55827.
84. Lee, P. R., Cohen, J. E., Iacobas, D. A., Iacobas, S., and Fields, R. D., "Gene networks
activated by specific patterns of action potentials in dorsal root ganglia neurons".
Scientific Reports (2017). 7(1): p. 43765.
85. Kiss, J. Z., Wang, C., Olive, S., et al., "Activity-dependent mobilization of the
adhesion molecule polysialic NCAM to the cell surface of neurons and endocrine
cells". Embo j (1994). 13(22): p. 5284-92.
86. Liu, T., Zhang, L., Joo, D., and Sun, S.-C., "NF-
κ B signaling in inflammation". Signal
Transduction and Targeted Therapy (2017). 2(1): p. 17023.
87. Ohtani, N., "The roles and mechanisms of senescence-associated secretory phenotype
(SASP): can it be controlled by senolysis?". Inflammation and Regeneration (2022).
42(1): p. 11.
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprintthis version posted August 9, 2025. ; https://doi.org/10.1101/2025.08.06.667201doi: bioRxiv preprint
30
88. Coppé, J. P., Desprez, P. Y., Krtolica, A., and Campisi, J., "The senescence-associated
secretory phenotype: the dark side of tumor suppression". Annu Rev Pathol (2010). 5:
p. 99-118.
89. Li, X., Chentao, L., Zhang, W., et al., "Inflammation and aging: signaling pathways
and intervention therapies". Signal Transduction and Targeted Therapy (2023). 8.
90. Li, R., Teng, Y., Guo, Y., et al., "Aging-related decrease of histone methyltransferase
SUV39H1 in adipose-derived stem cells enhanced SASP". Mechanisms of Ageing and
Development (2023). 215: p. 111868.
91. Demaria, M., Ohtani, N., Youssef, S. A., et al., "An essential role for senescent cells in
optimal wound healing through secretion of PDGF-AA". Dev Cell (2014). 31(6): p.
722-33.
92. Gellhaar, S., Sunnemark, D., Eriksson, H., Olson, L., and Galter, D.,
"Myeloperoxidase-immunoreactive cells are significantly increased in brain areas
affected by neurodegeneration in Parkinson's and Alzheimer's disease". Cell Tissue
Res (2017). 369(3): p. 445-454.
93. Ginsberg, S. D., Hemby, S. E., Lee, V. M. Y., Eberwine, J. H., and Trojanowski, J. Q.,
"Expression profile of transcripts in Alzheimer's disease tangle‐ bearing CA1
neurons". Annals of neurology (2000). 48(1): p. 77-87.
94. Fernández-Montoya, J. and Pérez, M., "Cathepsin D in a murine model of
frontotemporal dementia with Parkinsonism-linked to chromosome 17". Journal of
Alzheimer’s Disease (2015). 45(1): p. 1-14.
95. Khurana, V., Elson-Schwab, I., Fulga, T. A., et al., "Lysosomal dysfunction promotes
cleavage and neurotoxicity of tau in vivo". PLoS genetics (2010). 6(7): p. e1001026.
96. Vidoni, C., Follo, C., Savino, M., Melone, M. A. B., and Isidoro, C., "The Role of
Cathepsin D in the Pathogenesis of Human Neurodegenerative Disorders". Medicinal
Research Reviews (2016). 36(5): p. 845-870.
97. Wang, Z., Kennedy, B. K., Wong, L.-W., and Sajikumar, S., "Aging inverts the effects
of p75-modulated mTOR manipulation on hippocampal neuron synaptic plasticity in
male mice". The FASEB Journal (2023). 37(8): p. e23067.
98. Shetty, M. S., Sharma, M., and Sajikumar, S., "Chelation of hippocampal zinc
enhances long
‐ term potentiation and synaptic tagging/capture in CA 1 pyramidal
neurons of aged rats: implications to aging and memory". Aging Cell (2017). 16(1): p.
136-148.
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprintthis version posted August 9, 2025. ; https://doi.org/10.1101/2025.08.06.667201doi: bioRxiv preprint
31
99. Norris, C. M., Korol, D. L., and Foster, T. C., "Increased susceptibility to induction of
long-term depression and long-term potentiation reversal during aging". Journal of
Neuroscience (1996). 16(17): p. 5382-5392.
100. Marttinen, M., Kurkinen, K. M. A., Soininen, H., Haapasalo, A., and Hiltunen, M.,
"Synaptic dysfunction and septin protein family members in neurodegenerative
diseases". Molecular Neurodegeneration (2015). 10(1): p. 16.
101. Kay, A. D., Petzold, A., Kerr, M., et al., "Alterations in Cerebrospinal Fluid
Apolipoprotein E and Amyloid β -Protein after Traumatic Brain Injury". Journal of
Neurotrauma (2003). 20(10): p. 943-952.
102. Franz, G., Beer, R., Kampfl, A., et al., "Amyloid beta 1-42 and tau in cerebrospinal
fluid after severe traumatic brain injury". Neurology (2003). 60(9): p. 1457-61.
103. Bero, A. W., Yan, P., Roh, J. H., et al., "Neuronal activity regulates the regional
vulnerability to amyloid-β deposition". Nature Neuroscience (2011). 14(6): p. 750-756.
104. Hefter, D., Ludewig, S., Draguhn, A., and Korte, M., "Amyloid, APP, and Electrical
Activity of the Brain". Neuroscientist (2020). 26(3): p. 231-251.
105. Itoh, T., Takao, S., Shozo, N., et al., "Expression of amyloid precursor protein after
rat traumatic brain injury". Neurological Research (2009). 31(1): p. 103-109.
106. Chen, X. H., Johnson, V. E., Uryu, K., Trojanowski, J. Q., and Smith, D. H., "A lack
of amyloid beta plaques despite persistent accumulation of amyloid beta in axons of
long-term survivors of traumatic brain injury". Brain Pathol (2009). 19(2): p. 214-23.
107. Pooler, A. M., Phillips, E. C., Lau, D. H. W., Noble, W., and Hanger, D. P.,
"Physiological release of endogenous tau is stimulated by neuronal activity". EMBO
reports (2013). 14(4): p. 389-394-394.
108. Berlind, J. E., Lai, J. D., Lie, C., et al., "KCTD20 suppression mitigates excitotoxicity
in tauopathy patient organoids". Neuron (2025).
109. Liu, M. C., Kobeissy, F., Zheng, W., et al., "Dual vulnerability of tau to calpains and
caspase-3 proteolysis under neurotoxic and neurodegenerative conditions". ASN
Neuro (2011). 3(1): p. e00051.
110. Xia, Y., Lloyd, Grace M., and Giasson, Benoit I., "Targeted proteolytic products of
τ
and α -synuclein in neurodegeneration". Essays in Biochemistry (2021). 65(7): p. 905-
912.
111. Chu, D., Yang, X., Wang, J., et al., "Tau truncation in the pathogenesis of Alzheimer’s
disease: a narrative review". Neural Regeneration Research (2024). 19(6).
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprintthis version posted August 9, 2025. ; https://doi.org/10.1101/2025.08.06.667201doi: bioRxiv preprint
32
112. Gu, J., Xu, W., Jin, N., et al., "Truncation of Tau selectively facilitates its pathological
activities". Journal of Biological Chemistry (2020). 295(40): p. 13812-13828.
113. Chen, H.-H., Liu, P., Auger, P., et al., "Calpain-mediated tau fragmentation is altered
in Alzheimer’s disease progression". Scientific Reports (2018). 8(1): p. 16725.
114. Hosfield, C. M., Elce, J. S., Davies, P. L., and Jia, Z., "Crystal structure of calpain
reveals the structural basis for Ca2+‐dependent protease activity and a novel
mode of enzyme activation". The EMBO Journal (1999). 18(24): p. 6880-6889.
115. Kitagaki, H., Tomioka, S., Yoshizawa, T., et al., "Autolysis of calpain large subunit
inducing irreversible dissociation of stoichiometric heterodimer of calpain". Biosci
Biotechnol Biochem (2000). 64(4): p. 689-95.
116. Elce, J. S., Hegadorn, C., and Arthur, J. S., "Autolysis, Ca2+ requirement, and
heterodimer stability in m-calpain". J Biol Chem (1997). 272(17): p. 11268-75.
117. Johnston, I. D., McCluskey, D. K., Tan, C. K. L., and Tracey, M. C., "Mechanical
characterization of bulk Sylgard 184 for microfluidics and microengineering".
Journal of Micromechanics and Microengineering (2014). 24: p. 035017.
118. Feeney, D. M., Boyeson, M. G., Linn, R. T., Murray, H. M., and Dail, W. G.,
"Responses to cortical injury: I. Methodology and local effects of contusions in the
rat". Brain Research (1981). 211(1): p. 67-77.
119. Ma, X., Aravind, A., Pfister, B. J., Chandra, N., and Haorah, J., "Animal Models of
Traumatic Brain Injury and Assessment of Injury Severity". Molecular Neurobiology
(2019). 56(8): p. 5332-5345.
120. Li, X., Cui, D., Jiruska, P., et al., "Synchronization measurement of multiple neuronal
populations". J Neurophysiol (2007). 98(6): p. 3341-8.
121. Lee, S. H., Park, Y. M., Kim, D. W., and Im, C. H., "Global synchronization index as
a biological correlate of cognitive decline in Alzheimer's disease". Neurosci Res
(2010). 66(4): p. 333-9.
122. Latora, V. and Marchiori, M., "Efficient Behavior of Small-World Networks". Physical
Review Letters (2001). 87(19): p. 198701.
123. Ward Jr, J. H., "Hierarchical Grouping to Optimize an Objective Function". Journal
of the American Statistical Association (1963). 58(301): p. 236-244.
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprintthis version posted August 9, 2025. ; https://doi.org/10.1101/2025.08.06.667201doi: bioRxiv preprint
33
Supporting Information
A 3D Human Neuron-on-Chip Platform to Monitor Neuronal Injury Responses
Ruiping Tang, Charles-Francois Latchoumane, Avi Chopra, Marzan Sarkar, Chunki Kim,
Nathan Gonsalves, Hsueh-Fu Wu, Isha Mhatre-Winters, Aditya Mishra, Nadja Zeltner, Jason
R. Richardson, Lohitash Karumbaiah*
Figure S1. (hPFC cells demonstrate decreased proliferation and increased neuronal
differentiation 9 days post device-seeding. (A) Edu+ staining of hPFC cells reveals
significantly reduced cell proliferation 9 days post device seeding. Two-way ANOVA.
Uncorrected Fisher’s LSD, ***P<0.001, ****P<0.0001. n = 5 images per sample, data
represents 3 independent experiments. (B) Representative confocal image of
immunohistochemically stained HuC/D (pan-neuronal marker), GFAP (astrocyte marker), and
Olig2 (oligodendrocytes marker), scale – 200 µm. (C) Quantification of (B) demonstrating a
major presence of HuC/D+ neurons in PFC culture 2 weeks post device seeding. n = 5
images per sample from 3 independent experiments.)
Figure S2. (Weight-drop injury induces changes in cell body retraction and morbidity in
response to increasing impact force. Plots demonstrating significant changes in cell body
retraction (A), and cell death (B) with increasing impact force. Two-way ANOVA.
Uncorrected Fisher’s LSD, ***P<0.001, ****P<0.0001. (C) Scatter dot plot demonstrating
significantly enhanced cell death in the weight drop injured group, compared to uninjured
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprintthis version posted August 9, 2025. ; https://doi.org/10.1101/2025.08.06.667201doi: bioRxiv preprint
34
control. Two-way ANOVA, Ptime < 0.0001, Ptreatment < 0.0001, Pinteraction = 0.1541 with
Fisher’s LSD, ***p<0.001, ****p<0.0001. n = 5 images per ROI, 2 ROIs per device, 3
devices per group from 3 independent experiments.)
Figure S3. (Injury induces significant changes in neuronal activity at 0.5h, 24h, and 8d post
injury. (A-D) tSNE plot of sample distribution and their 95% CI eclipses on neuronal
functions described by 13 neuronal activity parameters reveals significant differences in
neuronal activity patterns between injury and control groups at 0.5h, 24h and 8d post injury.
PERMANOVA, P-Group = 0.001, iter = 1000. Bonferroni pairwise comparison, P value
indicated in each plot. Transparent makers in each plot indicates samples from other time
points.)
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprintthis version posted August 9, 2025. ; https://doi.org/10.1101/2025.08.06.667201doi: bioRxiv preprint
35
Figure S4. (Injury induces an acute increase in neuronal connectivity and disruption of
network structure. (A, B) nD and PL indicate acute increase and subsequent loss of functional
connections. (C, D) NoC (C, neuronal subcommunities) identified by an eigen-value-based
algorithm, and Modularity (D, sub-community presence) demonstrate acute disruption of
community structure in response to injury. (E) Representative heatmaps of pair-wise phase
locking matrix from control and injured groups 0.5 h post injury indicate remodeling of
functional network structure in response to the injury. Two-way ANOVA with Fisher’s LSD
test multiple comparison, *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001. n = 3-5 per time
point from 4 independent experiments.)
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprintthis version posted August 9, 2025. ; https://doi.org/10.1101/2025.08.06.667201doi: bioRxiv preprint
36
Figure S5. (Western blot analysis of calpain-1 and caspase-3. (A, B) Western blotting results
of calpain-1 levels 0.5 hr – 8 days post injury. (C, D) Western blotting results of caspase-3
levels 0.5 hr – 8 days post injury.)
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprintthis version posted August 9, 2025. ; https://doi.org/10.1101/2025.08.06.667201doi: bioRxiv preprint
37
Figure S6. (Loss of overall connectivity and long-range connections post injury. Histograms
demonstrate the loss of neurons with high connectivity (A-E) and long-range connection (F-J)
over time post-injury in the injured groups when compared to controls.)
Figure S7. (Acute decrease in global efficiency and cluster coefficient post-injury. (A-B)
Network analysis demonstrated an injury induced acute alteration of Global Efficiency (A),
and Cluster Coefficient (B). Two-way ANOVA with Fisher’s LSD test multiple comparison,
*P<0.05, **P<0.01, ***P<0.001, ****P<0.0001. n = 3-5 per time point across 4 independent
experiments.)
Figure S8. (Dysregulation of calcium trafficking 5-8 days post injury. (A-D) GSI (A), mRT
(B), mFT (C), mBW (D) revealing a statistically insignificant but increasing trend in injured
neurons 5-8 days post injury compared to control. Two-way ANOVA with Fisher’s LSD test
multiple comparison, *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001. n = 3-5 per time
points across 4 independent experiments.)
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprintthis version posted August 9, 2025. ; https://doi.org/10.1101/2025.08.06.667201doi: bioRxiv preprint
38
Figure S9. (Intracellular accumulation of pathologically relevant tau. (A) Western blotting